Hindustan Unilever Limited has successfully completed the divestment of its entire 19.8% shareholding in Nutritionalab Private Limited for approximately ₹307 crore, according to a regulatory filing dated March 4, 2026. This strategic transaction represents a significant portfolio optimization move by the FMCG major.

Transaction Details

The company informed stock exchanges BSE and NSE about the completion of this divestment under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. This follows the initial announcement made on February 12, 2026, regarding the proposed sale of the shareholding.

Strategic Portfolio Optimization

This divestment aligns with Hindustan Unilever's broader strategy of focusing on core business operations while optimizing its investment portfolio. The transaction enables the company to reallocate capital more efficiently across its primary FMCG business segments and growth initiatives.

The successful completion of this sale demonstrates the company's ability to execute strategic transactions and realize substantial value from its investments. Such portfolio optimization moves are typically undertaken to enhance operational focus and improve capital allocation efficiency.

Financial Impact and Capital Deployment

The ₹307 crore proceeds from this divestment will provide Hindustan Unilever with enhanced financial flexibility. This capital can be deployed towards strengthening the company's core FMCG operations, funding growth initiatives, or other strategic priorities as determined by management.

The transaction represents a complete exit from the Nutritionalab investment, allowing the company to concentrate its resources on areas where it can achieve greater strategic alignment and operational synergies. The clean divestment underscores the company's commitment to optimizing its investment portfolio for enhanced returns and operational focus.

Hindustan Unilever Limited delivered robust financial performance in the quarter ended 31st December 2025, reporting 6% revenue growth driven by strong underlying fundamentals and strategic initiatives. The company achieved 5% underlying sales growth and 4% underlying volume growth, marking its highest volume growth performance in the last 12 quarters.

Financial Performance Highlights

The company's financial metrics demonstrated solid execution across key parameters:

EBITDA margins remained healthy at 23.3%, staying within the company's previously guided range. The reported profit after tax of Rs. 6,603 crores included several one-off impacts from the ice cream demerger and OZiva fair valuation adjustments.

Segment-Wise Performance Analysis

Home Care Segment

Home Care delivered mid-single-digit underlying volume growth with 3% underlying sales growth. The segment achieved its highest ever market share, strengthening the company's leadership position. Fabric wash recorded competitive mid-single digit volume growth, while household care maintained strong momentum with double-digit volume growth.

Beauty & Wellbeing Segment

Beauty & Wellbeing posted 6% underlying sales growth, driven by outstanding performance in hair care and health & wellbeing categories. Hair care delivered double-digit growth supported by high-single digit volume growth, led by premium brands including Dove and TRESemmé.

Personal Care Performance

Personal Care achieved 6% underlying sales growth, led by double-digit growth in premium skin cleansing and oral care categories. The company continued reinforcing market leadership with double-digit growth in bodywash, accelerating market development activities in this category.

Foods Business Results

Foods delivered 6% underlying sales growth with broad-based performance driven by high-single digit volume growth. Tea recorded mid-single digit volume growth, while coffee continued strong double-digit growth momentum supported by both price and volume improvements.

Strategic Portfolio Transformation

The company completed several significant portfolio moves during the quarter:

The Board approved acquiring the remaining 49% stake in OZiva at an investment of Rs. 824 crores, reflecting the brand's strong performance and growth potential in the health & wellbeing segment.

Operational Excellence and Future Focus

The company established a dedicated quick commerce organization to capture the rapidly growing channel opportunity. Quick commerce currently contributes around 3% of business and is doubling every quarter. Service levels improved by 1,400 basis points over the past year, with lead times reducing by 20%.

Management implemented organizational changes to enhance agility and decision-making speed. All business unit heads now report directly to the CEO, eliminating the previous dual reporting structure to accelerate India-focused choices.

Market Outlook and Guidance

Management expressed confidence in sustained growth momentum, citing improving macro conditions including lower inflation, enhanced consumer sentiment, and supportive monetary policies. The company expects the second half of FY26 to perform better than the first half, with FY27 expected to deliver superior performance compared to FY26.

CEO Priya Nair emphasized the company's strategic focus on competitive volume-led revenue growth, supported by consumer segmentation, brand modernization, and enhanced marketing capabilities. The company continues prioritizing growth while maintaining EBITDA margins within the guided range of 22% to 23%.